PHARMAGREEN BIOTECH INC. Comprehensive Income
PHARMAGREEN BIOTECH INC. reported Comprehensive Income of -$51.48 thousand for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-02-14
- PHARMAGREEN BIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was -$51.48K, a 416.58% decline year-over-year.
- PHARMAGREEN BIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-06-30 was $292.82K.
- PHARMAGREEN BIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-03-31 was -$1.05M.
- PHARMAGREEN BIOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-12-31 was $16.26K.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month |
|---|---|---|---|
| 2022-12-31 | -$51.48K 10-Q · filed 2023-02-14 | ||
| 2022-06-30 | $292.82K 10-Q · filed 2022-08-17 | -$760.39K derived: sum of 2 quarters · filed 2022-08-17 | -$744.13K 10-Q · filed 2022-08-17 |
| 2022-03-31 | -$1.05M 10-Q · filed 2022-05-16 | -$1.04M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $16.26K 10-Q · filed 2023-02-14 | ||
| 2021-06-30 | -$155.36K 10-Q · filed 2022-08-17 | -$3.31M derived: sum of 2 quarters · filed 2022-08-17 | -$3.77M 10-Q · filed 2022-08-17 |
| 2021-03-31 | -$3.15M 10-Q · filed 2022-05-16 | -$3.61M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | -$459.56K 10-Q · filed 2022-02-22 |